Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 30.40
+0.20 (0.66%)
Jan 9, 2026, 1:35 PM CST
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 23.42 billion as of January 9, 2026. Its market cap has decreased by -33.85% in one year.
Market Cap
23.42B
Enterprise Value
25.77B
Revenue
70.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.40
Market Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 23.42B, a decrease of -49.58%. That is a compound annual growth rate of -6.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 23.42B | -2.25% |
| Dec 31, 2025 | 23.96B | -29.66% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 228.62B |
| PharmaEssentia | 189.36B |
| Lotus Pharmaceutical | 76.92B |
| Bora Pharmaceuticals Co., LTD. | 64.12B |
| Heron Neutron Medical | 59.70B |
| Oneness Biotech | 33.15B |
| Lumosa Therapeutics | 31.67B |
| Center Laboratories | 30.53B |